University of Chicago Celiac Disease Database

Celiac Disease Database

Sponsors

Lead sponsor: University of Chicago

Source University of Chicago
Brief Summary

The focus of this study is to create a database containing information about patients with celiac disease. This database will allow us to examine clinical and epidemiologic features of the University of Chicago Medical Center patient population. We have the largest population of patients with celiac disease in the mid-West and as such this study using information gathered from our database can greatly contribute to our current understanding of this disease.

Detailed Description

This database will allow us to examine clinical and epidemiologic features of the University of Chicago Medical Center patient population.

Overall Status Recruiting
Start Date September 2008
Completion Date September 2025
Primary Completion Date September 2025
Study Type Observational
Enrollment 3500
Condition
Eligibility

Sampling method: Non-Probability Sample

Criteria:

Inclusion Criteria:

- Must be a patient at The University of Chicago Medical Center

- Clinical diagnosis of celiac disease or gluten sensitivity

Exclusion Criteria:

- Currently being treated at a healthcare facility other than The University of Chicago Medical Center

- Not diagnosed with celiac disease or gluten sensitivity

Gender: All

Minimum age: N/A

Maximum age: 70 Years

Healthy volunteers: No

Overall Official
Last Name Role Affiliation
Stefano Guandalini, MD Principal Investigator University of Chicago
Overall Contact

Last name: Stefano Guandalini, MD

Phone: 773-702-6418

Email: [email protected]

Location
facility status contact investigator The University of Chicago Medical Center Stefano Guandalini, MD 773-702-3572 [email protected] Stefano Guandalini, MD Principal Investigator
Location Countries

United States

Verification Date

April 2020

Responsible Party

Responsible party type: Sponsor

Keywords
Has Expanded Access No
Condition Browse
Study Design Info

Observational model: Case-Only

Time perspective: Other

Source: ClinicalTrials.gov